ai3Bio

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Ability Biologics

The company develops antibody biotherapeutics using artificial intelligence for patients with cancer, autoimmune and inflammatory diseases.

Ability Biologics

The company develops AI-engineered antibody biotherapeutics targeting autoimmune diseases and cancer for patients with unmet medical needs.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

Lifordi

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with autoimmune and inflammatory disorders.

Laigo Bio

This company develops bispecific antibody therapies that remove disease-causing membrane proteins to treat patients with cancer and autoimmune disorders.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.